HUTCHMED (China) (HMDCF) EBIT Margin (2015 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly EBIT Margin came in at 172.21% in Q4 2021, down 150.71% quarter-over-quarter from 339.61% in Q3 2021.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) EBIT Margin (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported EBIT Margin for 6 consecutive years, with 172.21% the latest figure, recorded in Q4 2021.
- On a quarterly basis, EBIT Margin changed N/A year-over-year to 172.21% in Q4 2021; TTM through Dec 2021 was 20.62%, a N/A change from a year earlier, with the FY2025 full-year figure at 7.14%, down 20.0% from the prior year.
- EBIT Margin was 172.21% for Q4 2021 at HUTCHMED (China), down from 339.61% in the prior quarter.
- Over five years, EBIT Margin peaked at 339.61% in Q3 2021 and troughed at 303.37% in Q4 2018.
- A 4-year average of 18.22% and a median of 11.33% in 2018 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin plunged 37387 bps in 2019 and soared 31422 bps in 2020, its largest moves.
- Over 4 years, EBIT Margin stood at 303.37% in 2018, then soared by 76 bps to 72.05% in 2019, then surged by 236 bps to 98.23% in 2020, then plunged by 275 bps to 172.21% in 2021.
- The last three EBIT Margin figures came in at 172.21% (Q4 2021), 339.61% (Q3 2021), and 103.69% (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 30.15% |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | 32.54% |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | -562.07% |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | -23.56% |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | -25,380.93% |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -172.21% |
| Sep 28, 2021 | 339.61% |
| Jun 30, 2021 | -103.69% |
| Mar 31, 2021 | 278.72% |
| Jun 30, 2020 | 98.23% |
| Mar 31, 2020 | 274.29% |
| Dec 31, 2019 | -72.05% |
| Sep 30, 2019 | -72.83% |
| Jun 30, 2019 | -216.00% |
| Mar 31, 2019 | 69.10% |
| Dec 31, 2018 | -303.37% |
| Sep 30, 2018 | 25.14% |
| Jun 30, 2018 | 157.88% |
| Mar 31, 2018 | -47.81% |
| Jun 30, 2016 | 27.90% |
| Jun 30, 2015 | 22.11% |